Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The target action date for orforglipron is now April 10.

Novo Nordisk's weight loss pill could give the company's numbers a big boost this year.

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week and could change obesity care. Here’s how the Wegovy pill works, who qualifies, how to take it, side effects, cost, and what this ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

Here’s what the science says.

The daily oral Wegovy pill, much like the injectable version, is designed to be “used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...